Nuvalent
NUVL
NUVL was delisted on the 14th of July, 2026.
196 hedge funds and large institutions have $6.26B invested in Nuvalent in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 74 increasing their positions, 61 reducing their positions, and 34 closing their positions.
21% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 61
14% more capital invested
Capital invested by funds: $5.49B → $6.26B (+$777M)
0.3% more ownership
Funds ownership: 108.31% → 108.62% (+0.3%)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
6% less funds holding
Funds holding: 209 → 196 (-13)
26% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 34
49% less call options, than puts
Call options by funds: $3.36M | Put options by funds: $6.66M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$98.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$57.3M |
| 3 |
JP Morgan Chase
New York
|
+$37.7M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$32.1M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$16.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$110M |
| 2 |
Pictet Asset Management
Carouge,
Switzerland
|
-$16.2M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
-$12.9M |
| 4 |
Morgan Stanley
New York
|
-$11.7M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$11.6M |
NUVL Hedge Fund Activity: Q3 2025 in Review
196 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Nuvalent (NUVL) for Q3 2025, worth a combined $6.26B — up 14% from $5.49B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of NUVL and 25 opened new positions — a net loss of 9 holders — while 61 trimmed existing stakes and 74 added.
The largest buyer was RA Capital Management, opening a new position worth an estimated $98.6M. The largest seller was Bain Capital Life Sciences Investors, exiting entirely with an estimated $110M sold.
- 196 institutional investors held Nuvalent (NUVL) as of Q3 2025, down from 209 in Q2 2025.
- Funds reported $6.26B of Nuvalent stock for Q3 2025, up 14% quarter-over-quarter.
- 25 funds opened new Nuvalent positions in Q3 2025 and 34 closed out, a net change of -9 holders.
- The largest Nuvalent buyer in Q3 2025 was RA Capital Management, an estimated $98.6M added.
- The largest Nuvalent seller in Q3 2025 was Bain Capital Life Sciences Investors, an estimated $110M sold.
Based on aggregated 13F filings for Q3 2025.